Dr. McCarthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-4074Fax+1 716-845-3272- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1985 - 1989
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1982 - 1985
- Tufts University School of MedicineClass of 1982
Certifications & Licensure
- NY State Medical License 1996 - 2025
- MA State Medical License 1987 - 2016
- TX State Medical License 1992 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer Start of enrollment: 1998 Oct 19
- Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer Start of enrollment: 1998 Sep 01
- Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia Start of enrollment: 2002 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies.Saeed Daneshmandi, Jee Eun Choi, Qi Yan, Cameron R MacDonald, Mounika Goruganthu, Nathan Roberts, Prashant K Singh, Richard M Higashi, Andrew N Lane, Teresa W-M Fan, J...> ;Nature Communications. 2024 Mar 30
- A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help.Kevin J Curran, Sarah Nikiforow, Carlos Bachier, Yen-Michael Hsu, Marcela V Maus, Basem William, Kara Wacker, Phyllis Warkentin, Helen E Heslop, David Maloney, Philip ...> ;Blood Advances. 2024 Feb 27
- Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study.Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin Alousi, Asad Bashey, Robert Lowsky, David B Miklos, John Hansen, Peter Wester...> ;Bone Marrow Transplantation. 2024 Mar 1
- Join now to see all
Abstracts/Posters
- Genome Wide Interaction Analysis Identifies Expression Quantitative Trait Loci Associated with Reduced Survival after Reduced Intensity Conditioning HLA-Matched Unrela...Philip L. McCarthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)Philip L. McCarthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- _2- Adrenergic Signaling Regulates Graft Versus Host Disease after Allogenic Transplantation While Preserving Graft Versus Leukemia EffectPhilip L. McCarthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
- Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023
- Roswell Park Oncology Experts Named to Castle Connolly ‘Top Doctors’ ListAugust 4th, 2022
- Roswell Park Researchers Identify Key Link Between Stress and CancerNovember 5th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Hospital Affiliations
- Roswell Park Comprehensive Cancer CenterBuffalo, New York
External Links
- Roswell Park Cancer Institutehttps://www.roswellpark.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: